US2014193384A1PendingUtilityA1

Use of lactobacillus for liver protection

Assignee: UNIV CHINA MEDICALPriority: Aug 29, 2012Filed: Mar 12, 2014Published: Jul 10, 2014
Est. expiryAug 29, 2032(~6.1 yrs left)· nominal 20-yr term from priority
A61P 35/00A61P 7/00A61P 3/06A61P 3/00A61P 1/16A61P 1/18A23V 2002/00A61K 35/747A23L 33/135A23V 2400/169
44
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method for liver protection of a mammal is provided and includes administering an effective amount of isolated Lactobacillus plantarum CMU995 thereto. Providing a new use of Lactobacillus plantarum CMU995, which is deposited at the Food Industry Research and Development Institute (FIRDI) in Taiwan under accession number BCRC 910472 and in the German Collection of Microorganisms and Cell Cultures (DSMZ) under accession number DSM 23780.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A probiotic composition for liver protection comprising powdered  Lactobacillus plantarum  CMU995, wherein the concentration of the powdered  Lactobacillus plantarum  CMU995 is 1×10 5  CFU/g to 1×10 12  CFU/g, and the  Lactobacillus plantarum  CMU995 is deposited at the Food Industry Research and Development Institute (FIRDI) in Taiwan under accession number BCRC 910472 and in the German Collection of Microorganisms and Cell Cultures (DSMZ) under accession number DSM 23780. 
     
     
         2 . The probiotic composition according to  claim 1 , wherein the probiotic composition is in the form of a pharmaceutical composition, a feed, a drink, a nutrient supplement, a diary, a food, or a healthy food. 
     
     
         3 . The probiotic composition according to  claim 1 , wherein the probiotic composition is used for treating hepatitis caused by alcohol and endotoxin, and reducing endotoxin-induced liver lesions and/or hepatocarcinogenesis. 
     
     
         4 . The probiotic composition according to  claim 1  wherein the probiotic composition is in the form of a powder, a tablet, a granule, a suppository, a capsule, an ampoule, a liquid, or a spray.

Join the waitlist — get patent alerts

Track US2014193384A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.